New opportunities of evaluation of ischemic stroke secondary prophylaxis effectiveness in therapeutic practice
Aim. Study of antibodies to NR2-subunit of NMDA receptor level dynamics in patients after first ischemic stroke (IS) after use of Mildronate® 1000 mg per day. Materials and methods. The study included 45 patients (25 male, 20 female) aged 45 to 83 years at the time of first IS development. The pat...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ZAO "Consilium Medicum"
2019-02-01
|
| Series: | Consilium Medicum |
| Subjects: | |
| Online Access: | http://consilium.orscience.ru/en/archive/2019/vol-21-2-2019/new-opportunities-of-evaluation-of-ischemic-stroke-secondary-prophylaxis-effectiveness-in-therapeuti_5388/?element |